Researcher.Life Logo

Journal of Drug Targeting : Impact Factor & More

eISSN: 1029-2330pISSN: 1061-186X

Aims and Scope of Journal of Drug Targeting

Journal of Drug Targeting is a peer-reviewed medical journal published by Informa that covers research on all aspects of drug delivery and drug targeting for molecular and macromolecular drugs. The editor in chief is Saghir Akhtar (College of Medicine, Qatar University). Less

Key Metrics

CiteScore
8.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmaceutical Science
SNIP
0.85
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Drug Targeting

Journal of Drug Targeting Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Drug Targeting ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Drug Targeting

Development of Venlafaxine Hydrochloride Nasal Thermosensitive In-Situ Gel with P407/P188: Enhanced Bioavailability and Antidepressant Effects in Depressive Rats
  • 20 Apr 2026
  • Journal of Drug Targeting
Targeted delivery of Naringenin-enriched mannosylated niosomal nanogel for effective therapy of skin cancer
  • 20 Apr 2026
  • Journal of Drug Targeting
Nanomedicines for Neurodegenerative Ageing: Nasal Delivery Innovations for Alzheimer’s and Parkinson’s Disease
  • 16 Apr 2026
  • Journal of Drug Targeting
Advanced co-delivery nanocarriers to overcome drug resistance in breast cancer: carrier-mediated synergistic treatment by chemotherapy and gene therapy
  • 16 Apr 2026
  • Journal of Drug Targeting
Therapeutic potential of mesenchymal stem cells-derived exosomes loaded with elemental or nano selenium on diabetic nephropathy
  • 16 Apr 2026
  • Journal of Drug Targeting
Potential role of PVP/poloxamer 407 nanofibers loaded with resveratrol nanocrystals in skin cancer therapy
  • 9 Apr 2026
  • Journal of Drug Targeting
Development of Venlafaxine Hydrochloride Nasal Thermosensitive In-Situ Gel with P407/P188: Enhanced Bioavailability and Antidepressant Effects in Depressive Rats
  • 20 Apr 2026
  • Journal of Drug Targeting
Targeted delivery of Naringenin-enriched mannosylated niosomal nanogel for effective therapy of skin cancer
  • 20 Apr 2026
  • Journal of Drug Targeting
Nanomedicines for Neurodegenerative Ageing: Nasal Delivery Innovations for Alzheimer’s and Parkinson’s Disease
  • 16 Apr 2026
  • Journal of Drug Targeting
Advanced co-delivery nanocarriers to overcome drug resistance in breast cancer: carrier-mediated synergistic treatment by chemotherapy and gene therapy
  • 16 Apr 2026
  • Journal of Drug Targeting
Therapeutic potential of mesenchymal stem cells-derived exosomes loaded with elemental or nano selenium on diabetic nephropathy
  • 16 Apr 2026
  • Journal of Drug Targeting
Potential role of PVP/poloxamer 407 nanofibers loaded with resveratrol nanocrystals in skin cancer therapy
  • 9 Apr 2026
  • Journal of Drug Targeting

FAQs on Journal of Drug Targeting